Profile of HIV Seropositive Patients (PHSP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20130317081645im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
The aim of this study was to delineate the epidemiological profile of HIV seropositive patients on antiretroviral therapy at the Clinical Hospital of the Federal University of Goiás.
Condition |
---|
HIV Infection HIV Infections |
Study Type: | Observational |
Study Design: | Time Perspective: Retrospective |
Official Title: | Profile of HIV Seropositive Patients on Antiretroviral Therapy at the Clinical Hospital of the Federal University of Goiás |
- Data regarding the personal aspects, aspects related to the infection and information about the most used therapeutic. [ Time Frame: Since the start of the drug therapy ( means of 36 months) ] [ Designated as safety issue: Yes ]
Enrollment: | 222 |
Study Start Date: | June 2009 |
Study Completion Date: | September 2009 |
Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
HIV seroposite patients
Seroposite HIV patients that take their treatment at the Clinical Hospital of The Federal University of Goias, and have their records in the hospital.
|
Detailed Description:
Objective: To delineate the epidemiological profile of HIV seropositive patients on antiretroviral therapy at the Clinical Hospital of the Federal University of Goiás.
Methods: The present study is documental and analitical descriptive and it was conducted at the Clinical Hospital of the Federal University of Goiás, trough data collection of 222 records of individuals in drug therapy. Data were collected regarding the personal aspects, aspects related to the infection and information about the most used therapeutic.
![](https://webarchive.library.unt.edu/web/20130317081645im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Community sample, with HIV, in drug therapy in the Clinical Hospital of UFG.
Inclusion Criteria:
- All of the patients that had data in the hospital
- All with the diagnose of HIV
- Using antiretroviral drugs
Exclusion Criteria:
- Incompleted records
- Patients who didn't take their medicines regularly.
![](https://webarchive.library.unt.edu/web/20130317081645im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
![](https://webarchive.library.unt.edu/web/20130317081645im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Additional Information:
No publications provided
Responsible Party: | Caroline Nayanna Rodrigues Santos, Universidade Federal de Goiás |
ClinicalTrials.gov Identifier: | NCT00981279 History of Changes |
Other Study ID Numbers: | 129/2009, CONEP- 129/2009 |
Study First Received: | September 19, 2009 |
Last Updated: | October 28, 2009 |
Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Universidade Federal de Goias:
Health Profile AIDS Health Promotion HIV treatment experienced |
Additional relevant MeSH terms:
HIV Infections Acquired Immunodeficiency Syndrome HIV Seropositivity Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on March 14, 2013